DE602004022578D1 - Antitumorale terpen-verbindungen - Google Patents

Antitumorale terpen-verbindungen

Info

Publication number
DE602004022578D1
DE602004022578D1 DE602004022578T DE602004022578T DE602004022578D1 DE 602004022578 D1 DE602004022578 D1 DE 602004022578D1 DE 602004022578 T DE602004022578 T DE 602004022578T DE 602004022578 T DE602004022578 T DE 602004022578T DE 602004022578 D1 DE602004022578 D1 DE 602004022578D1
Authority
DE
Germany
Prior art keywords
antitumoral
terpen
compounds
relates
present
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
DE602004022578T
Other languages
English (en)
Inventor
Ifor Delme Bowen
Ahmed Yasine Ali
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
COMPTON DEVELOPMENTS Ltd
Original Assignee
COMPTON DEVELOPMENTS Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by COMPTON DEVELOPMENTS Ltd filed Critical COMPTON DEVELOPMENTS Ltd
Publication of DE602004022578D1 publication Critical patent/DE602004022578D1/de
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/01—Hydrocarbons
    • A61K31/015—Hydrocarbons carbocyclic
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/01—Hydrocarbons
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/32—Burseraceae (Frankincense family)
    • A61K36/328—Commiphora, e.g. mecca myrrh or balm of Gilead
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A61P35/02—Antineoplastic agents specific for leukemia

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Natural Medicines & Medicinal Plants (AREA)
  • Epidemiology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Microbiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Mycology (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Alternative & Traditional Medicine (AREA)
  • Biotechnology (AREA)
  • Botany (AREA)
  • Medical Informatics (AREA)
  • Hematology (AREA)
  • Oncology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)
DE602004022578T 2003-11-13 2004-11-12 Antitumorale terpen-verbindungen Active DE602004022578D1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GBGB0326518.8A GB0326518D0 (en) 2003-11-13 2003-11-13 Anti-cancer compounds
PCT/GB2004/004769 WO2005049001A1 (en) 2003-11-13 2004-11-12 Anti-tumour terpene compounds

Publications (1)

Publication Number Publication Date
DE602004022578D1 true DE602004022578D1 (de) 2009-09-24

Family

ID=29726508

Family Applications (1)

Application Number Title Priority Date Filing Date
DE602004022578T Active DE602004022578D1 (de) 2003-11-13 2004-11-12 Antitumorale terpen-verbindungen

Country Status (12)

Country Link
US (1) US20070259056A1 (de)
EP (1) EP1682107B1 (de)
JP (1) JP2007511492A (de)
KR (1) KR20060121177A (de)
CN (2) CN1882319B (de)
AT (1) ATE439126T1 (de)
AU (1) AU2004290946B2 (de)
CA (1) CA2545717A1 (de)
DE (1) DE602004022578D1 (de)
DK (1) DK1682107T3 (de)
GB (1) GB0326518D0 (de)
WO (1) WO2005049001A1 (de)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN101849981B (zh) * 2010-06-22 2011-11-23 南京中医药大学 一种具有抗妇科肿瘤作用的没药有效部位及其制备方法和其应用
US9220675B2 (en) 2010-09-09 2015-12-29 Mary Kay Inc. Topical skin care formulations comprising plant extracts
US11191745B2 (en) * 2017-02-03 2021-12-07 City Of Hope Silica nanoparticle with an insoluble drug
WO2020033567A1 (en) * 2018-08-07 2020-02-13 University Of Florida Research Foundation Methods and compositions for substituted arylcycloheptane analogs
CN110960518B (zh) * 2019-12-31 2022-12-20 河南大学 金丝大菊提取物在制备抗肿瘤药物中的应用

Family Cites Families (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5190979A (en) * 1988-06-24 1993-03-02 Stephen Herman Ozonides of terpenes and their medical uses
US6350784B1 (en) * 1996-02-12 2002-02-26 Meryl J. Squires Antimicrobial prevention and treatment of human immunedeficiency virus and other infectious diseases
US5602184A (en) 1993-03-03 1997-02-11 The United States Of America As Represented By Department Of Health And Human Services Monoterpenes, sesquiterpenes and diterpenes as cancer therapy
US5876728A (en) * 1995-02-15 1999-03-02 Howard David Kass Natural composition extracted from plants used in the treatment of cancer
AUPO316796A0 (en) * 1996-10-23 1996-11-14 Hood, John James David Essential oil
US6464839B1 (en) 1997-04-14 2002-10-15 Yuan Da International Group Limited Beta-elemene, method to prepare the same and uses thereof
US6265639B1 (en) * 1998-01-22 2001-07-24 Washington State University Foundation Gymnosperm nucleic acid molecules encoding sesquiterpene synthases and methods of use
FR2808196A1 (fr) 2000-04-27 2001-11-02 Andre Rougereau Nouveaux medicaments a base de melanges de sesquiterpenes
FR2811899B1 (fr) * 2000-07-20 2003-02-07 Anne Marie Pierrette Giraud Association d'huiles essentielles et applications therapeutiques
US6486706B2 (en) 2000-12-06 2002-11-26 Intel Corporation Domino logic with low-threshold NMOS pull-up
EP1351678A2 (de) * 2001-01-02 2003-10-15 Elizabeth Shanahan-Prendergast Behandlung von neoplastischen erkrankungen mit incensol und/oder furanogermacren
WO2002080951A1 (en) * 2001-04-06 2002-10-17 Synergistix Biotech, Inc. Herbal extracts for the treatment of cancer
GB0210152D0 (en) * 2002-05-02 2002-06-12 Compton Developments Ltd Use of plant materials
US20060241130A1 (en) * 2003-01-31 2006-10-26 Ehud Keinan Anti-inflammatory compositions and uses thereof
US20050074509A1 (en) * 2003-10-02 2005-04-07 Data Medica Padova S.P.A. Cancer treatment using natural plant products or essential oils extracted from some pistacia species or components

Also Published As

Publication number Publication date
CA2545717A1 (en) 2005-06-02
AU2004290946B2 (en) 2010-04-22
EP1682107A1 (de) 2006-07-26
CN1882319B (zh) 2010-08-25
GB0326518D0 (en) 2003-12-17
ATE439126T1 (de) 2009-08-15
DK1682107T3 (da) 2009-12-14
WO2005049001A1 (en) 2005-06-02
EP1682107B1 (de) 2009-08-12
KR20060121177A (ko) 2006-11-28
AU2004290946A1 (en) 2005-06-02
JP2007511492A (ja) 2007-05-10
CN101862365A (zh) 2010-10-20
US20070259056A1 (en) 2007-11-08
CN1882319A (zh) 2006-12-20

Similar Documents

Publication Publication Date Title
BR0312573A (pt) Derivados de fenil-[4-(3-fenil-1h-pirazol-4-il)-pirimidin-2-il]-amina
TW200716157A (en) Pharmaceutical formulations and methods of treatment using the same
GB0119249D0 (en) Organic compounds
MX2009006742A (es) Inhibidores acilaminopirazoles como fgfr.
CY1112478T1 (el) Ενωσεις κιναζολινονης ως αντικαρκινικοι παραγοντες
WO2002080890A3 (en) A jasmonate pharmaceutical composition for treatment of cancer
TW200640499A (en) Process for producing sterile suspensions of slightly soluble basic peptide complexes, sterile suspensions of slightly soluble basic peptide complexes, pharmaceutical formulations containing them, and the use thereof as medicaments
GB0112348D0 (en) Compounds
HUP0303271A2 (hu) Rapamycin felhasználása rák kezelésére alkalmas gyógyszerkészítmény elõállítására
EA201000643A1 (ru) Замещенное производное этилендиамина для лечения микобактериальных заболеваний и фармацевтическая композиция на его основе
CR8603A (es) Hidrocloruro de [4-(5-aminometil-2-fluoro-fenil)-piperidin-1-il]-(4-bromo-3-metil-5-propoxi-tiofen-2-il)-metanona como un inhibidor de la triptasa de mastocitos
SE0102440D0 (sv) New compound
SE9900070D0 (sv) New use
PL1718651T3 (pl) Pochodne 7H-pirolopirymidyny
DE602004022578D1 (de) Antitumorale terpen-verbindungen
SE0000303D0 (sv) Novel compounds
WO2003020371A3 (en) Potentiator composition comprising a terpene for enhancing a therapeutical effect of antitumoral agents in the treatment of cancer
DK1523985T3 (da) Ikke-radioaktivt strontiumholdigt middel til behandling af kræft
GB0305928D0 (en) Organic compounds
UA87292C2 (ru) Применение сирамезина для лечения злокачественных опухолей
ATE346080T1 (de) Steroid-verbindungen mit anti-tumoraler wirkung
AU2002359762A1 (en) Luminacin analogs and uses thereof
HN1999000145A (es) Uso de compuestos analogos a 1.3 oxatiolano-nucleosidos en la fabricacion de un medicamento para el tratamiento de la hepatitis b.
AU2003227008A1 (en) 2-methylthiazolidine-2,4-dicarboxylic acid and the salts thereof used for the treatment of neurodegenerative diseases
TW200621740A (en) Compound for treating hepatitis B and composition thereof

Legal Events

Date Code Title Description
8364 No opposition during term of opposition